Serum copper concentration and coronary heart disease among US adults

American Journal of Epidemiology

Volumn 151, Issue 12, 2000, Pages 1182-1188

  Ford, Earl S ^a  

^a NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

Author keywords

Cohort studies; Copper; Coronary disease

Indexed keywords

CHOLESTEROL; COPPER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; ATHEROGENESIS; ATOMIC ABSORPTION SPECTROMETRY; COHORT ANALYSIS; COPPER BLOOD LEVEL; COPPER METABOLISM; CORONARY ARTERY ATHEROSCLEROSIS; FEMALE; HUMAN; INFLAMMATION; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; UNITED STATES;

EID: 0033936128     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a010168     Document Type: Article

References (67)

1. Linder MC, Hazegh-Azam M. Copper biochemistry and molecular biology. Am J Clin Nutr 1996;63:797S-811S.
2. Centers for Disease Control and Prevention. Dietary intake of vitamins, minerals, and fiber of persons 2 months and over in the United States: Third National Health and Nutrition Examination Survey, phase 1, 1988-91. Advance data from Vital and Health Statistics, no. 258. Hyattsville, MD: National Center for Health Statistics, 1994.
3. Steinberg D, Parthasarathy S, Carew TE, et al. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915-24.
4. Fuster V, Badimon L, Badimon JJ, et al. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992;326:242-50.
5. Schroeder HA. The role of trace elements in cardiovascular diseases. Med Clin North Am 1974;58:381-96.
6. Punsar S, Erametsa O, Karvonen MJ, et al. Coronary heart disease and drinking water. A search in two Finnish male cohorts for epidemiologic evidence of a water factor. J Chronic Dis 1975;28:259-87.
7. Punsar S, Karvonen MJ. Drinking water quality and sudden death. Adv Cardiol 1978;25:25-6.
8. Marier JR. Role of environmental magnesium on cardiovascular disease. Magnesium 1982;1:266-76.
9. Manthey J, Stoeppler M, Morgenstern W, et al. Magnesium and trace metals: risk factors for coronary heart disease? Association between blood levels and angiographic findings. Circulation 1981;64:722-9.
10. Kinsman GD, Howard AN, Stone DL, et al. Studies in copper status and atherosclerosis. Biochem Soc Trans 1990;18:1186-8.
11. Singh RB, Gupta UC, Mittal N, et al. Epidemiologic study of trace elements and magnesium on risk of coronary artery disease in rural and urban Indian populations. J Am Coll Nutr 1997;16:62-7.
12. Harman D. Role of serum copper in coronary atherosclerosis. (Abstract). Circulation 1963;28:658.
13. Kanabrocki EL, Case LF, Fields T, et al. Manganese and copper levels in human urine. J Nucl Med 1965;6:780-91.
14. Kanabrocki EL, Case LF, Graham L, et al. Non-dialyzable manganese and copper levels in serum of patients with various diseases. J Nucl Med 1967;8:166-72.
15. Misra R, Bhambal SA, Misra NP, et al. Serum copper, ceruloplasmin & iron in ischaemic heart disease. Indian Heart J 1978;30:339-44.
16. Sullivan JF, Blotcky AJ, Jetton MM, et al. Serum levels of selenium, calcium, copper magnesium, manganese and zinc in various human diseases. J Nutr 1979;109:1432-7.
17. Singh MM, Singh R, Khare A, et al. Serum copper in myocardial infarction - diagnostic and prognostic significance. Angiology 1985;36:504-10.
18. Bialkowska M, Hoser A, Szostak WB, et al. Hair zinc and copper concentration in survivors of myocardial infarction. Ann Nutr Metab 1987;31:327-32.
19. Jain VK, Mohan G. Serum zinc and copper in myocardial infarction with particular reference to prognosis. Biol Trace Elem Res 1991;31:317-22.
20. Albala C, Salazar G, Vio F, et al. Estudio de ingesta y niveles sericos de cobre como factor de riesgo de enfermedad ateromatosa. (In Spanish). Rev Med Chil 1997;125:887-92.
21. Niskanen J, Marniemi J, Piironen O, et al. Trace element levels in serum and urine of subjects who died of coronary heart disease. Acta Pharmacol Toxicol (Copenh) 1986;59(suppl 7): 340-3.
22. Kok FJ, Van Duijn CM, Hofman A, et al. Serum copper and zinc and the risk of death from cancer and cardiovascular disease. Am J Epidemiol 1988;128:352-9.
23. Salonen JT, Salonen R, Korpela H, et al. Serum copper and the risk of acute myocardial infarction: a prospective population study in men in eastern Finland. Am J Epidemiol 1991;134: 268-76.
24. Reunanen A, Knekt P, Aaran RK. Serum ceruloplasmin level and the risk of myocardial infarction and stroke. Am J Epidemiol 1992;136:1082-90.
25. National Center for Health Statistics. Plan and operation of the Second National Health and Nutrition Examination Survey 1976-80. Hyattsville, MD: National Center for Health Statistics, 1981. (DHHS publication no. (PHS) 81-1317).
26. Centers for Disease Control and Prevention. Plan and operation of the NHANES II Mortality Study 1992. Hyattsville, MD: National Center for Health Statistics, 1999. (DHHS publication no. (PHS) 99-1314).
27. Centers for Disease Control. Laboratory procedures used by the Clinical Chemistry Division, Centers for Disease Control, for the Second National Health and Nutrition Examination Survey (NHANES II), 1976-1980. Atlanta, GA: Centers for Disease Control, 1981.
28. Shah BV, Barnwell BG, Bieler GS. SUDAAN user's manual, version 7.5. Research Triangle Park, NC: Research Triangle Institute, 1997.
29. Adelstein SJ, Coombs TL, Vallee BL. Metalloenzymes and myocardial infarction. I. The relation between serum copper and ceruloplasmin and its catalytic activity. N Engl J Med 1956;255:105-9.
30. Kanabrocki EL, Fields T, Decker CF, et al. Neutron activation studies of biological studies: manganese and copper. Int J Appl Radiat 1964;15:175-90.
31. Anderson TW, Neri LC, Schreiber GB, et al. Ischaemic heart disease, water hardness and myocardial magnesium. Can Med Assoc J 1975;113:199-203.
32. Chipperfield B, Chipperfield JR. Differences in metal content of the heart muscle in death from ischemic heart disease. Am Heart J 1978;95:732-7.
33. Sharrett AR. The role of chemical constituents of drinking water in cardiovascular diseases. Am J Epidemiol 1979;110: 401-19.
34. Tiber AM, Sakhaii M, Joffe CD, et al. Relative value of plasma copper, zinc, lipids and lipoproteins as markers for coronary artery disease. Atherosclerosis 1986;62:105-10.
35. Oster O, Dahm M, Oelert H, et al. Concentrations of some trace elements (Se, Zn, Cu, Fe, Mg, K) in blood and heart tissue of patients with coronary heart disease. Clin Chem 1989; 35:851-6.
36. Heinecke JW, Rosen H, Chait A. Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture. J Clin Invest 1984;74:1890-4.
37. Liuzzo G, Biasucci LM, Gallimore JR, et al. The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 1994;331:417-24.
38. Klevay LM. Re: "Serum copper and the risk of acute myocardial infarction: a prospective population study in men in eastern Finland." (Letter). Am J Epidemiol 1992;135:832-3.
39. Salonen JT, Salonen R, Korpela H, et al. The authors reply. (Letter). Am J Epidemiol 1992;135:833-4.
40. Klevay LM. Ischemic heart disease as copper deficiency. Adv Exp Med Biol 1989;258:197-208.
41. Virtamo J, Huttunen JK. Minerals, trace elements and cardiovascular disease. An overview. Ann Clin Res 1988;20:102-13.
42. Lonnerdal B. Bioavailability of copper. Am J Clin Nutr 1996; 63:821S-9S.
43. Fischer PWF, L'Abbé MR, Giroux MR. Effects of age, smoking, drinking, exercise, and estrogen use on indices of copper status in healthy adults. Nutr Res 1990;10:1081-90.
44. Johnson PE, Milne DB, Lykken GI. Effects of age and sex on copper absorption, biological half-life, and status in humans. Am J Clin Nutr 1992;56:917-25.
45. Milne DB, Johnson PE. Assessment of copper status: effect of age and gender on reference ranges in healthy adults. Clin Chem 1993;39:883-7.
46. Herring BW, Leavell BS, Paixao LM, et al. Trace metals in human plasma and red blood cells. I. Observations of normal subjects. Am J Clin Nutr 1960;8:846-54.
47. Harman D. The free radical theory of aging: effect of age on serum copper levels. J Gerontol 1965;20:151-3.
48. Yunice AA, Lindeman RD, Czerwinski AW, et al. Influence of age and sex on serum copper and ceruloplasmin levels. J Gerontol 1974;29:277-81.
49. King JC, Raynolds WL, Margen S. Absorption of stable isotopes of iron, copper, and zinc during oral contraceptives use. Am J Clin Nutr 1978;31:1198-203.
50. Vir SC, Love AH. Zinc and copper nutriture of women taking oral contraceptive agents. Am J Clin Nutr 1981;34:1479-83.
51. Hinks LJ, Clayton BE, Lloyd RS. Zinc and copper concentrations in leucocytes and erythrocytes in healthy adults and the effect of oral contraceptives. J Clin Pathol 1983;36:1016-21.
52. Bunker VW, Hinks LJ, Lawson MS, et al. Assessment of zinc and copper status of healthy elderly people using metabolic balance studies and measurement of leucocyte concentrations. Am J Clin Nutr 1984;40:1096-102.
53. Chilvers DC, Jones MM, Selby PL, et al. Effects of oral ethinyl oestradiol and norethisterone on plasma copper and zinc complexes in post-menopausal women. Horm Metab Res 1985;17: 532-5.
54. Kromhout D, Wibowo AAE, Herber RFM, et al. Trace metals and coronary heart disease risk indicators in 152 elderly men (the Zutphen Study). Am J Epidemiol 1985;122:378-85.
55. Kant AK, Moser-Veillon PB, Reynolds RD. Dietary intakes and plasma concentrations of zinc, copper, iron, magnesium, and selenium of young, middle aged and older men. Nutr Res 1989;9:717-24.
56. Solomons NW. Trace elements in nutrition of the elderly. 2. SADDIs for copper, manganese, selenium, chromium, molybdenum, and fluoride. Postgrad Med 1986;79:251-4, 256-8, 263.
57. Turnlund JR. Copper. In: Shils ME, Olson JA, Shike M, eds. Modern nutrition in health and disease. Malvern, PA: Lea & Febiger, 1994.
58. Milne DB. Copper intake and assessment of copper status. Am J Clin Nutr 1998;67(suppl):1041S-5S.
59. Milne DB, Johnson PE, Klevay LM, et al. Effect of copper intake on balance, absorption, and status indices of copper in men. Nutr Res 1990;10:975-86.
60. Turnlund JR, Keen CL, Smith RG. Copper status and urinary and salivary copper in young men at three levels of dietary copper. Am J Clin Nutr 1990;51:65 8-64.
61. Milne DB. Assessment of copper nutritional status. Clin Chem 1994;40:1479-84.
62. Turnlund JR, Scott KC, Peiffer GL, et al. Copper status of young men consuming a low-copper diet. Am J Clin Nutr 1997;65:72-8.
63. National Research Council. Diet and health. Washington, DC: National Academy Press, 1989.
64. Milne DB. Gallager SK, Johnson LK, et al. Long term variability of selected parameters related to Zn, Cu, and Fe nutriture. (Abstract). Am J Clin Nutr 1985;41:842.
65. Solomons NW, Pineda O, Milne DB. Short-term intraindividual variability in plasma trace mineral elements. J Micronutr Anal 1986;2:55-65.
66. Gallagher SK, Johnson LK, Milne DB. Short-term and long-term variability of indices related to nutritional status. I: Ca, Cu, Fe, Mg, and Zn. Clin Chem 1989;35:369-73.
67. Turnlund JR. Human whole-body copper metabolism. Am J Clin Nutr 1998;67(suppl):960S-4S.